Inspirna, Inc.(formerly Rgenix, Inc.): Funding & Investors (Sep 2026)
Inspirna (previously Rgenix) is a clinical-stage biopharmaceutical organization growing first-in-class/top tier drug up-and-comers that target basic disease drivers. Our disclosure stage use RNA science to find novel RNA dysregulated malignant growth drivers that can be designated by little atoms and biologics. Clinical projects are first-in-class oral little particles being developed for patients with RAS freak CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
Inspirna, Inc.(formerly Rgenix, Inc.) has raised $50.0M across 1 funding round on record, the most recent a Series D of $50.0M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inspirna, Inc.(formerly Rgenix, Inc.) Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Inspirna, Inc.(formerly Rgenix, Inc.) Funding Rounds
Inspirna, Inc.(formerly Rgenix, Inc.) Founders and Leadership Team
No contact details are on record for this team yet.
Inspirna, Inc.(formerly Rgenix, Inc.) Funding Compared to Other Biotechnology Startups
Inspirna, Inc.(formerly Rgenix, Inc.)'s latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inspirna, Inc.(formerly Rgenix, Inc.) in Biotechnology and New York
Companies Similar to Inspirna, Inc.(formerly Rgenix, Inc.)
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Inspirna, Inc.(formerly Rgenix, Inc.) Funding FAQs
What does Inspirna, Inc.(formerly Rgenix, Inc.) do?
Inspirna (previously Rgenix) is a clinical-stage biopharmaceutical organization growing first-in-class/top tier drug up-and-comers that target basic disease drivers. Our disclosure stage use RNA science to find novel RNA dysregulated malignant growth drivers that can be designated by little atoms and biologics. Clinical projects are first-in-class oral little particles being developed for patients with RAS freak CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
How much funding has Inspirna, Inc.(formerly Rgenix, Inc.) raised?
Inspirna, Inc.(formerly Rgenix, Inc.) has raised $50.0M across 1 round on record. The most recent is a Series D of $50.0M announced in Jul 2022.
When did Inspirna, Inc.(formerly Rgenix, Inc.) last raise funding?
Inspirna, Inc.(formerly Rgenix, Inc.)'s most recent funding round on record is a Series D of $50.0M, announced in Jul 2022.
Who is the CEO of Inspirna, Inc.(formerly Rgenix, Inc.)?
Masoud Tavazoie is listed as CEO at Inspirna, Inc.(formerly Rgenix, Inc.).
Where is Inspirna, Inc.(formerly Rgenix, Inc.) headquartered?
Inspirna, Inc.(formerly Rgenix, Inc.) is based in New York, United States.
How many employees does Inspirna, Inc.(formerly Rgenix, Inc.) have?
Inspirna, Inc.(formerly Rgenix, Inc.) is in the 11-50 employee band.
How does Inspirna, Inc.(formerly Rgenix, Inc.)'s funding compare to other Biotechnology startups?
Inspirna, Inc.(formerly Rgenix, Inc.)'s latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Inspirna, Inc.(formerly Rgenix, Inc.) Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inspirna, Inc.(formerly Rgenix, Inc.) is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.